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Introduction: Indications for repair of abdominal hernia are well established and widely diffused. Controversies still
exist about the indication in using the different prosthetic materials and principally about the biological ones.
Material and methods: In February 2012, the Italian Biological Prosthesis Work-Group (IBPWG), counting a
background of 264 biologic implants, met in Bergamo (Italy) for 1-day meeting with the aim to elaborate a
decisional model on biological prosthesis use in abdominal surgery.
Results: A diagram to simplify the decisional process in using biologics has been elaborated.
Conclusion: The present score represents a first attempt to combine scientific knowledge and clinical expertise
in order to offer precise indications about the kind of biological mesh to use.
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Infection, Tissue loss, MeshIntroduction
Prosthetic abdominal wall surgical repair is a common
procedure [1,2]. Actually, about one million prostheses
per year for abdominal wall repair are used worldwide
[3]. Since the first description of a mesh use for abdom-
inal wall repairing [4] plenty of new material have been
introduced, first synthetic, but later biologic. Indications
for repair are well established and widely diffused [5].
However controversies still exist about the indication in
using the different materials and principally about the
biological ones. More than a dozen of biological pros-
thesis (BP) are currently available (Table 1). All of them
are derived from human or mammalian tissues [6]. It
has already been noted the major variability among
human dermis prosthesis than among the animal ones
in terms of mechanical and physical properties [6]. In* Correspondence: lansaloni@ospedaliriuniti.bergamo.it
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reproduction in any medium, provided the orfact xenograft products are obtained from a more uni-
form animal population with similar age and life histor-
ies, this allows producers to obtain more consistent
implants than from humans donors [6].
BP, independently from the origin, could be further
and basically divided into two main groups: cross-linked
and non-cross-linked. The difference between these
two groups is the proceeding the cross-linked are sub-
mitted to. The introduction of chemical cross-linking
between the collagen chains, strengthens the prosthesis
reducing the efficacy of bacterial and host collagenase
enzymes, thus the implant is less prone to degradation
in vivo [7,8].
On the basis of either the presence or not of the
cross-linking, biological prosthesis are divided into two
subgroups: the partially remodeling (over time) and the
completely remodeling ones. The partially remodeling
(cross-linked) prosthesis are made of porcine or human
dermal collagen and bovine pericardium collagen [6].
The completely remodeling (not cross-linked) ones areal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Biological prosthesis currently on the market
Name Manufacturer Tissue source Material X-linking
Alloderm LifeCell Human Acellular dermis No
AlloMax Bard Human Acellular dermis No
Flex HD Ethicon/MTF¥ Human Acellular dermis -
DermaMatrix MTF¥ Human Acellular dermis No
Permacol Covidien Porcine Acellular dermis Yes
CollaMend Davol/Bard Porcine Acellular dermis Yes
Strattice KCI/LifeCell Porcine Acellular dermis No
XenMatrix Brennan Medical Porcine Acellular dermis No
Surgisis Cook Porcine Small intestine submucosa No
Surgisis Gold Cook Porcine Small intestine submucosa No
Lyosis Cook Porcine Lyophilized small intestine submucosa No
FortaGen Organogenesis Porcine Small intestine submucosa Yes
SurgiMend TEI bioscience Bovine Fetal dermis No
Periguard Synovis Bovine Pericardium Yes
Veritas Synovis Bovine Pericardium No
Tutomesh Tutogen Bovine Pericardium No
Tutopatch Tutogen Bovine Pericardium No
¥ MTF: Muscoloskeletal Transplant Foundation.
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dermis, human dermis, fetal bovine dermis and bovine
pericardium. The differences in remodeling times should
be kept in mind when these materials are chosen for
abdominal wall repair [6]. Each type of prosthesis
allows and encourages host tissue ingrowth, although
different prostheses can feature different clinical attri-
butes. Thanks to the presence of additional linkages the
partially remodeling ones resist better and for a longer
period to mechanical stress. Moreover BP have the low-
est adhesiogenic potential among all prosthetic materials
available for intra-peritoneal use [9]. Post-operative pain
and discomfort have been demonstrated to be inferior
when biological prosthetic materials are used in groin
hernia repair [10]. Implants would act as a scaffold
inside which the host tissue cells and fibroblasts can rep-
licate. They also provide resistance to tension and stress
by supporting the abdominal wall until it is fully recov-
ered. Times of remodeling range between a few months
and few years [11]. It depends on prosthesis characteris-
tics and host tissues properties.
Surgeons have not widely assumed the capability to
manage with BP. The way to consider them should be
completely different from the standard synthetic meshes.
These last ones are as a “patch to apply on a hole”;
essentially they trigger a foreign body host response
leading to encapsulation of the prosthesis with intense
fibrous reaction. On the contrary BP activate a remodel-
ing process in which the host remodels the prosthesis
and his own tissues by producing new healthy tissue. By
using BP the surgeon starts a real tissue engineeringprocess [12]. The scarcity of knowledge about BP is also
due to the lack of high-evidence level literature about
the topic. For this reason the Italian Chapter of the
European Hernia Society has founded the Italian Regis-
ter of Biological Prosthesis (IRBP) to archive and study
the BP use in Italy. A similar registry associated with the
European Hernia Society, the European Register of Bio-
logical Prosthesis (ERBP), is currently recruiting cases all
over Europe [3].
To give an answer to the many different questions
about the BP use in abdominal surgery we promoted a
meeting of the Italian Biological Prosthesis Work-Group
(IBPWG) constituted by surgeons with a wide experi-
ence in abdominal surgery either in elective or in emer-
gency setting and in the use of BP. The purpose of
the summit was mainly to give a few simple and repro-
ducible indications about the correct use of BP in
abdominal wall surgery keeping into consideration the
two main challenges: the infected fields and the loss
of tissue.Material and methods
In February 2012, the IBPWG met in Bergamo (Italy) for
1-day summit with the aim to elaborate a decisional
model on BP use in abdominal surgery. The group is
constituted by general surgeons, all with extensive
experience in abdominal wall surgery either in elective
or in emergency setting, added to a wide experience in
the use of BP (at the time of the meeting the participants
had collectively implanted 284 BP).
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A diagram to simplify the decisional process in using BP
has been elaborated (Figures 1, 2). It keeps into consid-
eration the different kind of BP, the infection of the sur-
gical field and the tissue loss.
The diagram suggests the type of BP that should be
used by combining these three variables together on the
basis of scientific literature and expert opinions.
Discussion
Complex abdominal hernia repair represents a signifi-
cant challenge for surgeons. Complex hernia could be dif-
ferently defined. The complexity of hernias could derive
from contamination/infection, tissue loss, dimensions,
anatomic position and clinical or pharmacological data.
For sure the introduction of tension-free techniques,
thanks to the use of prosthetic materials, has greatly
facilitated the duty. On one hand prosthetic techniques
have been demonstrated to reduce the recurrence
rate, on the other hand they introduced a series of new
variables to take into consideration when repairing
abdominal wall defects: actually prosthetic infection, dis-
location, chronic pain, shrinkage, adhesions formation,
fistula formation and skin erosion complicate the deci-
sion process in abdominal wall repair surgery. With
the introduction of resorbable materials some of these
factors have been eliminated with an increased recur-
rence rate as a counterpart. BP has completely changed
the way to face the abdominal hernia surgery. They
introduced the tissue engineering in field of the surgical
practice [12]. The implant of biologic materials elicits
a cascade of events leading to new healthy tissueFigure 1 Decisional model diagram: the product of the infection and
the kind of biological prosthesis to use.deposition and prosthesis remodeling. It also allows to
blood, growth and pro-/anti-inflammatory factors and
drugs to reach the surgical field during the first phases
of healing process. This for sure enhances the effect
against potential or definite contamination/infection.
Moreover the adhesiogenic power of BP is absolutely
lower than the one of the other synthetic materials
[13,14]. On the contrary there are a few doubts about
the intra-peritoneal use of BP from the biomechanical
point of view. It has been demonstrated that the best
integration is reached if they are placed pre-peritoneally
with a greater incorporation strength, less adhesion
area and lower adhesion scores compared with intra-
peritoneal placement [15]. Given that the long-term per-
sistence of the prosthesis is crucial, some authors stated
that the BP durability has a direct impact on the recur-
rence rate [16]. However durability depends on the
implant intrinsic properties and also on the environment
into which the BP are placed [16]. It has been demon-
strated in animal models as the tensile strength is differ-
ent between cross-linked and non-cross-linked meshes
during the first months after the implant. However it
reaches similar values after 12 months with the two kind
of implants [8]. Moreover the strength of the repair sites
doesn’t change over time. This might indicate that new
tissue is deposited in the repair site as the scaffold is
degraded, preventing the site from weakening over time
[8]. Another factor that should be kept into account in
choosing which kind of BP to use is the demonstration
that non-cross-linked material exhibits more favourable
remodeling characteristics [8]. This has a great import-
ance when BP are used as bridging or alternatively asthe loss of tissue scores gives as a result the value which indicate
Figure 2 Decisional line: the different results indicate the kind of biological prosthesis to use.
Coccolini et al. World Journal of Emergency Surgery 2012, 7:34 Page 4 of 5
http://www.wjes.org/content/7/1/34reinforcement. In fact discordant data have been pub-
lished about the use of BP to bridge wide defects [16].
Few different non-randomized studies have been pub-
lished reporting recurrence rate ranging between 100%
and 0% if the prosthesis are placed respectively either as
a bridge or not [16-19]. Even if high-quality comparative
data about BP exist in animal models, only clinical
reports of a restricted number of cases are reported for
humans. Moreover only the recurrence rate is registered
as outcome in almost all studies. Other data regarding
the use of BP as wound classification, contamination
risk/grade, associated therapy or comorbidity are seldom
reported. These data are needed to completely assess the
usefulness, the efficacy and the versatility of BP. All
reported data derived by retrospective uncontrolled
series of limited number of patients. The methodology is
seldom reported and/or poorly described. Moreover the
time to recurrence is rarely evaluated [16]. One last ob-
servation is that the different studies reported data about
non-homogeneous cohorts of patients. Different surgical
techniques, different surgeons’ skill and expertise in
using BP and different hernia sites are often mixed
together. These inconsistencies are probably due to the
poorness of cases for each single centre. No definitive
evidence based conclusions could be obtained from the
literature. The majority of surgeons stated that they use
BP in “difficult” situations, especially those with con-
taminated or infected field [16,20,21].
The present decisional model suggests, at the best of
our knowledge, the way to apply scientific knowledge to
the clinical practice in order to choose which type of BP
use in abdominal wall defects repair. This should always
be a dynamic process mediated by the surgeon decisio-
nal capability. We resumed the principal variables to
keep in mind in deciding the kind of BP to use. Infection
has been divided into three possible grades:
– 1: potentially contaminated
– 2: contaminated
– 3: infected
The same three steps division has been adopted for
the tissue loss:
– 1: no tissue loss (only reinforcement)
– 2: 0–5 cm defect
– 3: >5 cm defectBy combining together these variables (multiplication)
we obtained a score which determine the necessity
to use either a cross-linked or a non-cross-linked BP
(Figures 1, 2).
Operating field has been divided into three groups. In
a previous grading system by the Ventral Hernia Work-
ing Group (VEWG) the four grade of risk for surgical
site occurrences have been differentiated by considering
also the comorbidity of the patients [5]. Clinical condi-
tions are to be kept in mind in evaluating the use
of prosthesis but in the present decisional model the
principal aim is to help the surgeon to decide whether
use cross-linked or non-cross-linked BP.
Undefined situations still exist. Cases with a score be-
tween 2 and 6 represent all that patients with a big
tissue loss and a potential/low grade infection or vice-
versa cases with an high grade infection and a low or
null tissue loss. These cases need a cautious evaluation
by the surgeon to establish if the priority has to be given
to the tissue loss or to the grade of infection. The
VEWG score could help in deciding. Infected fields with
no residual loss of tissue don’t represent an absolute in-
dication for BP use. On the contrary a small tissue loss
with concomitant low/null infection but high comorbid-
ity could suggest using a non-cross-linked BP. The
higher resistance to protease enzyme action and to
mechanical stress of cross-linked BP suggest using them
in situation of high infection and/or big defects. As
counterpart, however even in presence of a high grade
infection with a low grade tissue loss could be suggested
to place a non-cross-linked BP.
Conclusion
The present score represents the first combination of
scientific knowledge and clinical expertise that gives
some indications about the kind of BP to use. However
no definitive recommendations could be given in com-
plicated abdominal wall reconstructive surgery. The lack
of definitive evidence-based data and the high costs of
the BP suggest to cautiously evaluate each single case.
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